P138 Evaluation of germline mutation in high risk breast cancer cohort: compliance with NCCN 2023 v.1 testing criteria

• A. Kwong,
• C.Y. Ho,
• V.Y. Shin,
• W.P. Luk,
• L.H. Fung,
• C.H. Au,
• T.L. Chan,
• E.S. Ma

Affiliations

A. Kwong

C.Y. Ho

V.Y. Shin

W.P. Luk

L.H. Fung

C.H. Au

T.L. Chan

E.S. Ma